PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, Faculty of Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Yamanashi, 409-3898, Japan.\', \'Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki, 889-2192, Japan; Center for Animal Disease Control, University of Miyazaki, Miyazaki, 889-2192, Japan.\', \'Institute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka, 565-0871, Japan.\', \'Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, 567-0085, Japan.\', \'Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan.\', \'Department of Microbiology, Faculty of Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Yamanashi, 409-3898, Japan; Center for Life Science Research, University of Yamanashi, Yamanashi, 409-3898, Japan; Division of Hepatitis Virology, Institute for Genetic Medicine, Hokkaido University, Hokkaido, 060-0808, Japan. Electronic address: kmoriishi@yamanashi.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0166-3542(22)00036-510.1016/j.antiviral.2022.105268
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 35271914
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all